Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemoporfin photodynamic therapy phase IIb study in port-wine stain
ChiCTR-TRC-08000236Phase 2Completed
- Sponsor
- Peking University First Hospital
- Start
- Oct 2006
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of hemoporfin in port-wine stain (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Third party assessment. Started Oct 2006; status: completed.
02
Drugs
hemoporfin
03
Conditions
port-wine stain
Beyond the preview
Go deeper on ChiCTR-TRC-08000236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000236.